Question 1

What is EPTIFIBATIDE used for?

Accepted Answer

EPTIFIBATIDE (brand name Eptifibatide) is a Other indicated for new MI, or need for urgent intervention in patients undergoing PCI, including those undergoing intracoronary stenting [see Clinical Studies (14.1.

Question 2

How does EPTIFIBATIDE work?

Accepted Answer

EPTIFIBATIDE works through the following mechanism: 12.1 Mechanism of Action Eptifibatide reversibly inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive ligands to GP IIb/IIIa. When administered intravenously, eptifibatide inhibits ex vivo platelet aggregation in a dose- and concentration-dependent manner. Platelet aggregation inhibition is reversible following cessation of the eptifibatide infusion; this is thought to result from dissociation of eptifibatide from the platelet..

Question 3

What are the most common side effects of EPTIFIBATIDE?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for EPTIFIBATIDE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is EPTIFIBATIDE the same as Eptifibatide?

Accepted Answer

Eptifibatide is a brand name for EPTIFIBATIDE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

EPTIFIBATIDE

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations